Dr Baba Inusa MRCP, FRCPCH, DCP (Haem), FMCPaed is the lead clinician for the children's sickle cell and thalassaemia centre at Evelina London.
He is the principal investigator for a number of clinical and new drug trials in sickle cell disease. Some of these studies include:
- silent infarct transfusion trial (SITT)
- sickle asthma cohort study (SAC)
- sickle cell anaemia transcranial doppler educational clinical cohort study (SCATES).
He has published in a number of end organ disorders in sickle cell disease, including stroke, renal and respiratory disorders.
Before his current role, Baba was lead children's consultant for oncology at Queen Elizabeth II Hospital, Welwyn Garden City.
- National Secretary for the UK Forum on Haemoglobin Disorders - responsible for the development of sickle cell and thalassaemia standards and specifications
- serves on a number of Department of Health Sickle Cell and Thalassaemia screening committees, and is a member of the Clinical Reference Group (CRG)
- chair of the London Focus Sickle Cell Africa - a group of professionals with interest in global sickle cell management
- leads the team of specialists who established the Newborn Screening for Sickle Cell Disease in Nigeria (SCORE)
- joint children's lead for the Guy's and St Thomas' Arthur Davison Children's Hospital Zambia partnership.